Phenylketonuria Treatment Market By Treatment Type (Dietary Management, Medication {sapropterin dihydrochloride, pegvaliase}, Gene therapy), By Age group (Pediatrics, Adults), By End-User (Hospitals and Clinics, Homecare) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1543 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Treatment Type:

  • Dietary Management
  • Medications
    • Sapropterin Dihydrochloride
    • Pegvaliase
  • Gene Therapy

By Age group:

  • Pediatrics
  • Adults

By End-User:

  • Hospitals and Clinics
  • Homecare

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • BioMarin Pharmaceutical
  • Cambrooke Therapeutics
  • PTC Therapeutics
  • Erytech Pharma
  • Danone Nutricia
  • Homology Medicines
  • American Gene Technologies
  • Censa Pharmaceuticals
  • Vertex Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Enzyvant
  • AlfaSigma
  • Nutritional Medicinal
  • POA Pharma
  • Coriell Life Sciences
  • Synlogic Inc.
  • Codexis Inc.
  • Ultragenyx

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing